Skip to main content
Fig. 1 | Trials

Fig. 1

From: Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study

Fig. 1

A; * − t1: screen visit; t0: allocation/baseline visit; t1: 2 or 8 h before termination of pregnancy; t2: at the time of feticide; t3: at patient’s discharge. B: * − t1: screen visit; t0: allocation/baseline visit; t1: 3 days before induction; t2: day 1 after first sildenafil administration; t3: 50 h after first sildenafil administration; t4: at beginning of labor; t5: at delivery; t6: day 1 after delivery; t7: at maternal and neonatal discharge

Back to article page